FI844786A0 - Terapeutiskt utnyttjbar foerening. - Google Patents

Terapeutiskt utnyttjbar foerening.

Info

Publication number
FI844786A0
FI844786A0 FI844786A FI844786A FI844786A0 FI 844786 A0 FI844786 A0 FI 844786A0 FI 844786 A FI844786 A FI 844786A FI 844786 A FI844786 A FI 844786A FI 844786 A0 FI844786 A0 FI 844786A0
Authority
FI
Finland
Prior art keywords
utnyttjbar
foerening
terapeutiskt
imidazole
benzyl
Prior art date
Application number
FI844786A
Other languages
English (en)
Finnish (fi)
Inventor
Raimo Einari Virtanen
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Antti Tapani Vaehae-Vahe
Outi Maritta Vainio-Kivinen
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of FI844786A0 publication Critical patent/FI844786A0/fi
Priority to FI844786A priority Critical patent/FI844786A0/fi
Application filed by Farmos Oy filed Critical Farmos Oy
Priority to NZ213604A priority patent/NZ213604A/xx
Priority to ZA858416A priority patent/ZA858416B/xx
Priority to DK508985A priority patent/DK163960C/da
Priority to AU49971/85A priority patent/AU572364B2/en
Priority to AT85308748T priority patent/ATE65694T1/de
Priority to DE8585308748T priority patent/DE3583670D1/de
Priority to IE302485A priority patent/IE58269B1/en
Priority to EP85308748A priority patent/EP0187471B1/en
Priority to US06/804,197 priority patent/US4670455A/en
Priority to JP60272380A priority patent/JPS61134314A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Stringed Musical Instruments (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Photoreceptors In Electrophotography (AREA)
FI844786A 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening. FI844786A0 (fi)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FI844786A FI844786A0 (fi) 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening.
NZ213604A NZ213604A (en) 1984-12-04 1985-09-25 Use of 4-((alpha-methyl)-2,3-dimethylbenzyl)-imidazole as a veterinary sedative-analgesic agent
ZA858416A ZA858416B (en) 1984-12-04 1985-11-01 A therapeutically useful compound
DK508985A DK163960C (da) 1984-12-04 1985-11-05 Anvendelse af 4-((alfa-metyl)-2,3-dimetylbenzyl)-imidazol til fremstilling af veterinaere praeparater
AU49971/85A AU572364B2 (en) 1984-12-04 1985-11-15 4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field
AT85308748T ATE65694T1 (de) 1984-12-04 1985-12-02 Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum.
EP85308748A EP0187471B1 (en) 1984-12-04 1985-12-02 Use of a substituted imidazole for the manufacture of a medicament useful as a sedative or analgesic
DE8585308748T DE3583670D1 (de) 1984-12-04 1985-12-02 Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum.
IE302485A IE58269B1 (en) 1984-12-04 1985-12-02 A therapeutically useful compound
US06/804,197 US4670455A (en) 1984-12-04 1985-12-03 Method of bringing about sedation and/or analgesia in a mammal
JP60272380A JPS61134314A (ja) 1984-12-04 1985-12-03 獣医薬鎮静鎮痛剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI844786A FI844786A0 (fi) 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening.

Publications (1)

Publication Number Publication Date
FI844786A0 true FI844786A0 (fi) 1984-12-04

Family

ID=8520010

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844786A FI844786A0 (fi) 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening.

Country Status (11)

Country Link
US (1) US4670455A (cs)
EP (1) EP0187471B1 (cs)
JP (1) JPS61134314A (cs)
AT (1) ATE65694T1 (cs)
AU (1) AU572364B2 (cs)
DE (1) DE3583670D1 (cs)
DK (1) DK163960C (cs)
FI (1) FI844786A0 (cs)
IE (1) IE58269B1 (cs)
NZ (1) NZ213604A (cs)
ZA (1) ZA858416B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
WO2010065547A1 (en) * 2008-12-01 2010-06-10 Map Pharmaceuticals, Inc. Inhalation delivery methods and devices
WO2010074753A1 (en) * 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
ES2856189T3 (es) 2013-10-07 2021-09-27 Teikoku Pharma Usa Inc Métodos y composiciones para el tratamiento del trastorno de hiperactividad por déficit de atención, ansiedad e insomnio utilizando composiciones transdérmicas de dexmedetomidina
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
BR112016006848A2 (pt) 2013-10-07 2017-08-01 Teikoku Pharma Usa Inc métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
EP3562486B1 (en) 2016-12-31 2024-03-13 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
MX2020014000A (es) 2018-06-27 2021-06-15 Bioxcel Therapeutics Inc Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
DE3378118D1 (en) * 1982-08-14 1988-11-03 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations

Also Published As

Publication number Publication date
JPH0465050B2 (cs) 1992-10-16
DK163960C (da) 1992-09-21
AU4997185A (en) 1986-06-12
IE853024L (en) 1986-06-04
JPS61134314A (ja) 1986-06-21
AU572364B2 (en) 1988-05-05
IE58269B1 (en) 1993-08-25
DK163960B (da) 1992-04-27
ATE65694T1 (de) 1991-08-15
EP0187471A2 (en) 1986-07-16
US4670455A (en) 1987-06-02
DE3583670D1 (de) 1991-09-05
ZA858416B (en) 1986-07-30
DK508985D0 (da) 1985-11-05
DK508985A (da) 1986-06-05
EP0187471A3 (en) 1988-09-14
NZ213604A (en) 1988-09-29
EP0187471B1 (en) 1991-07-31

Similar Documents

Publication Publication Date Title
FI844786A0 (fi) Terapeutiskt utnyttjbar foerening.
ES2045229T3 (es) Pirrolidinas 1,3-disubstituidas.
NO854639L (no) Formgitte hydrogelgjenstander.
OA07710A (fr) Composés hétérocycliques azotés, de même que leur production et leur utilisation.
FI865025A7 (fi) 2-(3,5-dihalogeeni-4-aminobentsyyli) imidatsoliineja.
TR199801350T2 (xx) Yeni sikloalkil ikameli imidazoller.
FI850850L (fi) Antipsykotiska 1-fluorfenylbutyl-4-( 2-pyrimidinyl) piperazinderivat.
MX9301783A (es) Derivados de 1-[2-arilsulfonilamino)-etil-1-oxo]-piperidina, su preparacion y su aplicacion en terapeutica.
FI842115A0 (fi) Pressparti med separata pressnyp i en pappersmaskin.
DE3866309D1 (de) Laktonmodifizierte mannich-basen als dispergier-zusaetze, verwendbar in oeligen zusammensetzungen.
DE3579675D1 (de) Kombinierter lateraler mos/bipolarer transistor hoher leitfaehigkeit.
DE3684993D1 (de) Pufferkompensation in enzymmodofizierten, ionensensitiven vorrichtungen.
DE3587114D1 (de) Integriertes nachrichtennetz.
NO163573C (no) Vaskemiddeltilsetning.
FI851431A7 (fi) Imidatsolijohdannaisia.
FR2569569B1 (fr) Exerciseur destine notamment au travail du grand ecart.
IT1183423B (it) Amplificatore video di uscita, non suscettibile di saturazione
MX9202909A (es) 4-[alquilcarbonil(substituidas)]-4,5-dihidro- y -4,5,6,7-tetrahidro-7-[fenil(substituidas)]pirazolo-[1,5-a]pirimidinas .
KR840006230A (ko) 1-페닐-2-메틸-3-(1-피로리디닐)-1-프로판온 유도체의 제조방법
IT8521657A0 (it) 1-(2-pirimidinil)-piperazinilderivati di 1-pirrolidin-2-oni psicogeriatrici.
DK376882A (da) Fungicidt virksomme 1-(trihalogenmethylsulfenyl)-4-aryl-1,2,4-triazolidin-5-oner
FR2553410B1 (fr) Nouveaux derives de 2-tolyl-morpholine utiles en therapeutique
DE3582598D1 (de) Substituierte alkyliden-imidazole.
DE3587219D1 (de) Metallo-organo-aluminate als zusaetze.
DE3874361D1 (de) Als analgetika verwendbare 1-((4-morpholinyl)alkyl)-1h-indole und deren herstellung.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FARMOS-YHTYMAE OY